New approach identifies reproducible volatile organic compounds for lung cancer diagnosis
A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...
Overjoyed grandad, 81, given hope for life with new breakthrough cancer trial
EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...
EurekAlert!1d
New approach identifies reproducible VOCs for lung cancer diagnosis
A research team led by Prof. CHU Yannan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed a multi-medium approach (MMA) to identify reproducible volatile ...
Cure Today1d
Facing Cancer Together: Jim and Melanie’s Patient-Caregiver Story
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...
Too Old to Operate1d
In Lung Cancer, Novel Preoperative Biomarkers Predict Recurrence Risk
Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...
hospitalhealthcare3d
Lung cancer pathway insights from Dr Zaheer Mangera part 2: neoadjuvant therapy
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
Targeted Oncology4d
AI Prognostic Tool for NSCLC Earns FDA Breakthrough Designation
The FDA granted breakthrough status to Serial CTRS, an AI tool that improves survival predictions in non–small cell lung ...
Pharmabiz6d
Onc.AI receives US FDA’s breakthrough device designation for its serial CT response score deep learning model
Onc.AI receives US FDA’s breakthrough device designation for its serial CT response score deep learning model: San Carlos, California Saturday, February 8, 2025, 16:00 Hrs [IST] ...